Diagnosis and Management of Common Acquired Bleeding Disorders

被引:6
作者
De Simone, Nicole [1 ]
Sarode, Ravi [1 ]
机构
[1] UT Southwestern Med Ctr, Dept Pathol, Div Transfus Med & Hemostasis, Dallas, TX 75390 USA
关键词
acquired coagulopathy; disseminated intravascular coagulation; liver disease; warfarin reversal; new oral anticoagulants; PROTHROMBIN COMPLEX CONCENTRATE; INTERNATIONAL NORMALIZED RATIO; FACTOR-X DEFICIENCY; DISSEMINATED INTRAVASCULAR COAGULATION; ORAL ANTICOAGULANT TREATMENT; PARTIAL THROMBOPLASTIN TIME; LUPUS ANTICOAGULANT; HEMORRHAGIC COMPLICATIONS; VENOUS THROMBOEMBOLISM; ORGAN DYSFUNCTION;
D O I
10.1055/s-0032-1333539
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acquired bleeding disorders (ABD) are commonly encountered in both inpatient and outpatient settings. ABD can occur due to consumption, decreased synthesis, or inhibition of coagulation factors and platelets. Clinical presentation may vary, ranging from mild bruising to life-threatening hemorrhage. The location, frequency, severity, and provocation of bleeding provide insight into the cause of ABD. Obtaining a good medical, surgical, family, social, and medication history is a crucial step in determining the underlying etiology. Basic laboratory parameters, such as prothrombin time, partial thromboplastin time, thrombin time, fibrinogen, platelet count, and D-dimer levels, aid in further elucidating the reason for bleeding. Optimal management depends on accurate interpretation of the history and laboratory values. Treatment options include administration of vitamin K; blood component transfusion, consisting of plasma, cryoprecipitate, and/or platelets; and blood derivatives, including single and multiple factor concentrates. These products should be used judiciously, due to potential infectious and noninfectious complications, including transfusion-related acute lung injury and transfusion-associated circulatory overload. This article discusses the management of the more common causes of ABD.
引用
收藏
页码:172 / 181
页数:10
相关论文
共 80 条
[1]   D-dimer antigen: current concepts and future prospects [J].
Adam, Soheir S. ;
Key, Nigel S. ;
Greenberg, Charles S. .
BLOOD, 2009, 113 (13) :2878-2887
[2]  
[Anonymous], 2012, COCHRANE DATABAASE S, DOI DOI 10.1016/J.IMLET.2004.07.009
[3]   Pharmacology and management of the vitamin K antagonists [J].
Ansell, Jack ;
Hirsh, Jack ;
Hylek, Elaine ;
Jacobson, Alan ;
Crowther, Mark ;
Palareti, Gualtiero .
CHEST, 2008, 133 (06) :160S-198S
[4]   The molecular basis of quantitative fibrinogen disorders [J].
Asselta, R. ;
Duga, S. ;
Tenchini, M. L. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) :2115-2129
[6]   Diagnosis of lupus anticoagulant in the lupus anticoagulant-hypoprothrombinemia syndrome:: Report of two cases and review of the literature [J].
Baca, V ;
Montiel, G ;
Meillón, L ;
Pizzuto, J ;
Catalán, T ;
Juan-Shum, L ;
Nieva, B .
AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (03) :200-207
[7]  
BAJAJ SP, 1983, BLOOD, V61, P684
[8]   Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation [J].
Bakhtiari, K ;
Meijers, JCM ;
de Jonge, E ;
Levi, M .
CRITICAL CARE MEDICINE, 2004, 32 (12) :2416-2421
[9]   Presurgical plasma exchange is ineffective in correcting amyloid associated factor X deficiency [J].
Barker, B ;
Altuntas, F ;
Paranjape, G ;
Sarode, R .
JOURNAL OF CLINICAL APHERESIS, 2004, 19 (04) :208-210
[10]   Reversal of antithrombotic agents [J].
Bauer, Kenneth A. .
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 :S119-S126